Text
COVID-19 alters the local immunity of the lung in ways that weaken the body’s antimicrobial defense and facilitate the development of secondary infections.
The findings of a recent study suggest that phages can be used to treat IBD and other diseases associated with gut microbes.
RBX2660 is an investigational microbiota-based live biotherapeutic studied for its potential to reduce recurrence of C. difficile infection after antibiotic treatment
The Italian-based leader in the European nutraceutical CDMO market announces the acquisition of Nutraskills, a French company specialized in the research and development, production, and packaging of food supplements for…
The findings of a recent study suggest that engineered native gut bacteria could be employed to help treat certain diseases such as diabetes.
A recent study suggests that the microbiome changes in response to human consumption of non-nutritive sweetener may induce glycemic changes in consumers in a personalized manner.
The intestinal microflora of infants should contain a high proportion of Bifidobacteria during their first year of life to be well preserved and balanced
Company Presents Data at ESMO Congress Showing Link Between Gut Bacteria and Early Colorectal Cancer Detection
Antimicrobial resistant bacteria are present in newborns after just a few hours of life and they help to understand the routes of transmission of antibiotic-resistance genes.
The findings of a new research suggest that different responses to statins can be explained by the variation in the human microbiota.
